Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA: A Cancer. J Clin 73:17–48. https://doi.org/10.3322/caac.21763

Article  Google Scholar 

Cancer - PAHO/WHO| Pan American Health Organization https://www.paho.org/en/topics/cancer. Accessed 27 Dec 2023

Cancer https://www.who.int/health-topics/cancer. Accessed 27 Dec 2023

Santos MDO, Lima FCDSD, Martins LFL et al (2023) Estimativa De Incidência De Câncer no Brasil, 2023–2025. https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3700. Rev Bras Cancerol 69:

Wendt C, Margolin S (2019) Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer. Acta Oncol 58:135–146. https://doi.org/10.1080/0284186x.2018.1529428

Article  CAS  PubMed  Google Scholar 

PDQ Adult Treatment Editorial Board (2002) Breast Cancer Treatment (PDQ®): Health Professional Version. PDQ Cancer Information Summaries. National Cancer Institute (US). Bethesda (MD)

Debela DT, Muzazu SG, Heraro KD et al (2021) New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med 9:20503121211034366. https://doi.org/10.1177/20503121211034366

Article  PubMed  PubMed Central  Google Scholar 

Pantziarka P, Capistrano IR, De Potter A et al (2021) An Open Access Database of Licensed Cancer drugs. Front Pharmacol 12:627574. https://doi.org/10.3389/fphar.2021.627574

Article  PubMed  PubMed Central  Google Scholar 

Anticancerfund (ed) (2021) https://www.anticancerfund.org/en/cancerdrugs-db. Accessed 27 Dec 2023

Chow LWC, Biganzoli L, Leo AD et al (2017) Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and caucasian breast cancer patients. Asia Pac J Clin Oncol 13:372–378. https://doi.org/10.1111/ajco.12682

Article  CAS  PubMed  Google Scholar 

Kim S, Kang SI, Kim S, Kim JH (2021) Prognostic implications of Chemotherapy-Induced Neutropenia in Stage III Colorectal Cancer. J Surg Res 267:391–396. https://doi.org/10.1016/j.jss.2021.05.002

Article  PubMed  Google Scholar 

Tao G, Huang J, Moorthy B et al (2020) Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity. Expert Opin Drug Metab Toxicol 16:1109–1124. https://doi.org/10.1080/17425255.2020.1815705

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akbarali HI, Muchhala KH, Jessup DK, Cheatham S (2022) Chemotherapy induced gastrointestinal toxicities. Adv Cancer Res 155:131–166. https://doi.org/10.1016/bs.acr.2022.02.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

da Silva EB, Chagas CS, Oliveira MPA et al (2019) Comparative study on myelotoxic and antineoplastic action of Synadenium umbellatum, Vitis vinifera and Resveratrol. J Nat Remedies 80–86. https://doi.org/10.18311/jnr/2019/23383

Safwat MA, Kandil BA, Elblbesy MA et al (2020) Epigallocatechin-3-gallate-loaded Gold nanoparticles: Preparation and evaluation of Anticancer Efficacy in Ehrlich Tumor-Bearing mice. Pharmaceuticals (Basel) 13:254. https://doi.org/10.3390/ph13090254

Article  CAS  PubMed  Google Scholar 

Brito WAS, Freund E, Nascimento TDH do, et al (2021) The Anticancer efficacy of plasma-oxidized saline (POS) in the Ehrlich Ascites Carcinoma Model in Vitro and in vivo. Biomedicines 9:932. https://doi.org/10.3390/biomedicines9080932

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandes PD, Guerra FS, Sales NM et al (2015) Characterization of the inflammatory response during Ehrlich ascitic tumor development. J Pharmacol Toxicol Methods 71:83–89. https://doi.org/10.1016/j.vascn.2014.09.001

Article  CAS  PubMed  Google Scholar 

Ozaslan M, Karagoz ID, Kilic IH, Guldur ME (2011) Ehrlich ascites carcinoma. Afr J Biotechnol 10:2375–2378. https://doi.org/10.4314/ajb.v10i13

Article  Google Scholar 

Nik ME, Momtazi-Borojeni AA, Zamani P et al (2019) Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment. J Cell Physiol 234:14721–14733. https://doi.org/10.1002/jcp.28230

Article  CAS  PubMed  Google Scholar 

Paidakula S, Nerella S, Kankala S, Kankala RK (2022) Recent trends in tubulin-binding combretastatin A-4 analogs for Anticancer Drug Development. Curr Med Chem 29:3748–3773. https://doi.org/10.2174/0929867328666211202101641

Article  CAS  PubMed  Google Scholar 

Chen Z-H, Xu R-M, Zheng G-H et al (2023) Development of Combretastatin A-4 Analogues as potential Anticancer agents with Improved Aqueous solubility. Molecules 28:1717. https://doi.org/10.3390/molecules28041717

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Figueiredo LP, Ibiapino AL, Amaral DN, do et al (2017) Structural characterization and cytotoxicity studies of different forms of a combretastatin A4 analogue. J Mol Struct 1147:226–234. https://doi.org/10.1016/j.molstruc.2017.06.093

Article  CAS  Google Scholar 

do Amaral DN, Cavalcanti BC, Bezerra DP et al (2014) Docking, synthesis and antiproliferative activity of N-Acylhydrazone derivatives designed as Combretastatin A4 analogues. PLoS ONE 9:e85380. https://doi.org/10.1371/journal.pone.0085380

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silva JC, Júnior RG, de O, Silva MG e, et al (2018) LASSBio-1586, an N-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice. PLoS ONE 13:e0199009. https://doi.org/10.1371/journal.pone.0199009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karatoprak GŞ, Küpeli Akkol E, Genç Y et al (2020) Combretastatins: an overview of structure, probable mechanisms of action and potential applications. Molecules 25:2560. https://doi.org/10.3390/molecules25112560

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sherbet GV (2020) Combretastatin analogues in cancer biology: a prospective view. J Cell Biochem 121:2127–2138. https://doi.org/10.1002/jcb.29342

Article  CAS  PubMed  Google Scholar 

Shahrasbi A, Armin A, Ardebili A et al (2017) Hematologic adverse effects following systemic chemotherapy. 2:1–3. https://doi.org/10.4172/2576-3857.1000110

de Oliveira Gozzo T, Nascimento TG, do, Panobianco MS, de Almeida AM (2011) Ocurrencia de neutropenia en mujeres con cáncer de mama durante El Tratamiento quimioterápico. Acta Paulista De Enfermagem 24:810–814. https://doi.org/10.1590/s0103-21002011000600014

Article  Google Scholar 

Niraj J, Färkkilä A, D’Andrea AD (2019) The Fanconi Anemia Pathway in Cancer. Annu Rev Cancer Biol 3:457–478. https://doi.org/10.1146/annurev-cancerbio-030617-050422

Article  PubMed  Google Scholar 

Gilreath JA, Rodgers GM (2020) How I treat cancer-associated anemia. Blood 136:801–813. https://doi.org/10.1182/blood.2019004017

Article  PubMed  Google Scholar 

Abiri B, Vafa M (2020) Iron Deficiency and Anemia in Cancer patients: the role of Iron Treatment in Anemic Cancer patients. Nutr Cancer 72:864–872. https://doi.org/10.1080/01635581.2019.1658794

Article  CAS  PubMed  Google Scholar 

Wang Y-J, Fletcher R, Yu J, Zhang L (2018) Immunogenic effects of chemotherapy-induced tumor cell death. Genes Dis 5:194–203. https://doi.org/10.1016/j.gendis.2018.05.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shrivastava S, Swati Shrivastava, Singh N et al (2016) Comparative study of hematological parameters along with effect of chemotherapy and radiotherapy in different stages of breast cancer. Int J Res Med Sci 5:311–315. https://doi.org/10.18203/2320-6012.ijrms20164569

Article  Google Scholar 

Coiffier B, Guastalla J-P, Pujade-Lauraine E et al (2001) Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey. Eur J Cancer 37:1617–1623. https://doi.org/10.1016/s0959-8049(01)00169-1

Article